Navigating Biopharma Commercialization:
The Interplay of Regulatory Affairs, Process
Development, and Manufacturing to Ensure
Drug Quality
Presenter:
Yves Scheurer is a pharmacist by education, having graduated with a degree in drug regulatory affairs from the University of Strasbourg in France (PharmD). Key contact across multiple business units (microbial, mammalian, bioconjugates, drug product), Yves helps customers achieve high-quality regulatory dossiers for clinical and commercial filing.
Robin Schumacher is a bioprocess engineer by training, having graduated from the University of Braunschweig in Germany and receiving a doctoral degree from Delft University of Technology in the Netherlands. With a strong background in microbial process technology and project commercialization, Robin currently serves program management, technical teams, and regulatory affairs in project coordination where he brings together regulatory and scientific know-how.
